Epigenetics and human disease

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 1, 2009, Pages 136-146

  Hirst, Martin ^a   Marra, Marco A ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Disease; Epigenetics

Indexed keywords

HISTONE;

AUTOIMMUNITY; CANCER CELL; CANCER GROWTH; DISEASE COURSE; DNA METHYLATION; DNA REPLICATION; DNA SEQUENCE; DNA STRAND; EPIGENETICS; HUMAN; REVIEW;

AUTOIMMUNE DISEASES; CHROMATIN; DISEASE; DNA; DNA METHYLATION; DNA REPLICATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 55949129030     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.09.011     Document Type: Review

References (160)

1. Akiyama Y., Maesawa C., Ogasawara S., Terashima M., and Masuda T. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 163 (2003) 1911-1919
2. Antequera F., and Bird A. Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90 (1993) 11995-11999
3. Badal V., Chuang L.S., Tan E.H., Badal S., Villa L.L., Wheeler C.M., et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77 (2003) 6227-6234
4. Barrett A., Madsen B., Copier J., Lu P.J., Cooper L., Scibetta A.G., et al. PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?. Int J Cancer 101 (2002) 581-588
5. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 129 (2007) 823-837
6. Bergemann A.D., Cole F., and Hirschhorn K. The etiology of Wolf-Hirschhorn syndrome. Trends Genet 21 (2005) 188-195
7. Bernstein B.E., Meissner A., and Lander E.S. The mammalian epigenome. Cell 128 (2007) 669-681
8. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006) 315-326
9. Bestor T.H. Transposons reanimated in mice. Cell 122 (2005) 322-325
10. Bhaumik S.R., Smith E., and Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol 14 (2007) 1008-1016
11. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 16 (2002) 6-21
12. Bird A. Perceptions of epigenetics. Nature 447 (2007) 396-398
13. Bohuslav J., Kravchenko V.V., Parry G.C., Erlich J.H., Gerondakis S., Mackman N., et al. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest 102 (1998) 1645-1652
14. Borrow J., Stanton Jr. V.P., Andresen J.M., Becher R., Behm F.G., Chaganti R.S., et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 14 (1996) 33-41
15. Brinkman A.B., Roelofsen T., Pennings S.W., Martens J.H., Jenuwein T., and Stunnenberg H.G. Histone modification patterns associated with the human X chromosome. EMBO Rep 7 (2006) 628-634
16. Bueno M.J., Perez de Castro I., Gomez de Cedron M., Santos J., Calin G.A., Cigudosa J.C., et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13 (2008) 496-506
17. Buschhausen G., Wittig B., Graessmann M., and Graessmann A. Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 84 (1987) 1177-1181
18. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 6 (2006) 857-866
19. Castro R., Rivera I., Struys E.A., Jansen E.E., Ravasco P., Camilo M.E., et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 49 (2003) 1292-1296
20. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320 (2008) 1224-1229
21. Chan C., Li L., McCall C.E., and Yoza B.K. Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. J Immunol 175 (2005) 461-468
22. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353 (2005) 1768-1771
23. Cho M., Uemura H., Kim S.C., Kawada Y., Yoshida K., Hirao Y., et al. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma. Br J Cancer 85 (2001) 563-567
24. Crawford D.C., Acuna J.M., and Sherman S.L. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 3 (2001) 359-371
25. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299 (2003) 1753-1755
26. Cunningham J.M., Christensen E.R., Tester D.J., Kim C.Y., Roche P.C., Burgart L.J., et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58 (1998) 3455-3460
27. Daskalakis M., Nguyen T.T., Nguyen C., Guldberg P., Kohler G., Wijermans P., et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-aza-2′-deoxycytidine (decitabine) treatment. Blood 100 (2002) 2957-2964
28. de Capoa A., Musolino A., Della Rosa S., Caiafa P., Mariani L., Del Nonno F., et al. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. Oncol Rep 10 (2003) 545-549
29. Edwards T.M., and Myers J.P. Environmental exposures and gene regulation in disease etiology. Environ Health Perspect 115 (2007) 1264-1270
30. Ehrlich M., Gama-Sosa M.A., Huang L.H., Midgett R.M., Kuo K.C., McCune R.A., et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res 10 (1982) 2709-2721
31. Esteller M. Epigenetics in cancer. N Engl J Med 358 (2008) 1148-1159
32. Faravelli F. NSD1 mutations in Sotos syndrome. Am J Med Genet C Semin Med Genet 137C (2005) 24-31
33. Fattaey A.R., Helin K., Dembski M.S., Dyson N., Harlow E., Vuocolo G.A., et al. Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene 8 (1993) 3149-3156
34. Feinberg A.P. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction. Cancer Res 59 (1999) 1743s-1746s
35. Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat Rev Cancer 4 (2004) 143-153
36. Feinberg A.P., and Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301 (1983) 89-92
37. Flanagan J.F., Mi L.Z., Chruszcz M., Cymborowski M., Clines K.L., Kim Y., et al. Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature 438 (2005) 1181-1185
38. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102 (2005) 10604-10609
39. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37 (2005) 391-400
40. Fraga M.F., Herranz M., Espada J., Ballestar E., Paz M.F., Ropero S., et al. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 64 (2004) 5527-5534
41. Gama-Sosa M.A., Midgett R.M., Slagel V.A., Githens S., Kuo K.C., Gehrke C.W., et al. Tissue-specific differences in DNA methylation in various mammals. Biochim Biophys Acta 740 (1983) 212-219
42. Gama-Sosa M.A., Slagel V.A., Trewyn R.W., Oxenhandler R., Kuo K.C., Gehrke C.W., et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11 (1983) 6883-6894
43. Gartler S.M., and Riggs A.D. Mammalian X-chromosome inactivation. Annu Rev Genet 17 (1983) 155-190
44. Gibbons R.J. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum Mol Genet 14 Spec No 1 (2005) R85-R92
45. Gluckman P.D., and Hanson M.A. The consequences of being born small-an adaptive perspective. Horm Res 65 Suppl. 3 (2006) 5-14
46. Godfrey K.M., Lillycrop K.A., Burdge G.C., Gluckman P.D., and Hanson M.A. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res 61 (2007) 5R-10R
47. Goldstone A.P. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 15 (2004) 12-20
48. Goll M.G., and Bestor T.H. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 74 (2005) 481-514
49. Graff J.R., Herman J.G., Lapidus R.G., Chopra H., Xu R., Jarrard D.F., et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55 (1995) 5195-5199
50. Grewal S.I., and Moazed D. Heterochromatin and epigenetic control of gene expression. Science 301 (2003) 798-802
51. Groth A., Rocha W., Verreault A., and Almouzni G. Chromatin challenges during DNA replication and repair. Cell 128 (2007) 721-733
52. He L., and Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5 (2004) 522-531
53. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39 (2007) 311-318
54. Henikoff S., Furuyama T., and Ahmad K. Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet 20 (2004) 320-326
55. Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91 (1994) 9700-9704
56. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.P., Davidson N.E., et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55 (1995) 4525-4530
57. Hoek H.W., Brown A.S., and Susser E. The Dutch famine and schizophrenia spectrum disorders. Soc Psychiatry Psychiatr Epidemiol 33 (1998) 373-379
58. Howard G., Eiges R., Gaudet F., Jaenisch R., and Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 27 (2008) 404-408
59. Humpherys D., Eggan K., Akutsu H., Hochedlinger K., Rideout III W.M., Biniszkiewicz D., et al. Epigenetic instability in ES cells and cloned mice. Science 293 (2001) 95-97
60. Jacinto F.V., Ballestar E., and Esteller M. Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome. Biotechniques 44 (2008) 35, 37, 39 passim
61. Jackson J.P., Lindroth A.M., Cao X., and Jacobsen S.E. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416 (2002) 556-560
62. Jaju R.J., Fidler C., Haas O.A., Strickson A.J., Watkins F., Clark K., et al. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15,5) in de novo childhood acute myeloid leukemia. Blood 98 (2001) 1264-1267
63. Jenner R.G., and Young R.A. Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 3 (2005) 281-294
64. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
65. Jiang Y.H., Bressler J., and Beaudet A.L. Epigenetics and human disease. Annu Rev Genomics Hum Genet 5 (2004) 479-510
66. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19 (1998) 187-191
67. Kahl P., Gullotti L., Heukamp L.C., Wolf S., Friedrichs N., Vorreuther R., et al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 66 (2006) 11341-11347
68. Kaneda A., and Feinberg A.P. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. Cancer Res 65 (2005) 11236-11240
69. Karpf A.R., and Matsui S. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 65 (2005) 8635-8639
70. Keshet I., Lieman-Hurwitz J., and Cedar H. DNA methylation affects the formation of active chromatin. Cell 44 (1986) 535-543
71. Klose R.J., Yan Q., Tothova Z., Yamane K., Erdjument-Bromage H., Tempst P., et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128 (2007) 889-900
72. Kornberg R.D. Chromatin structure: a repeating unit of histones and DNA. Science 184 (1974) 868-871
73. Kornberg R.D., and Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98 (1999) 285-294
74. Kouzarides T. Chromatin modifications and their function. Cell 128 (2007) 693-705
75. Landry J., Sutton A., Hesman T., Min J., Xu R.M., Johnston M., et al. Set2-catalyzed methylation of histone H3 represses basal expression of GAL4 in Saccharomyces cerevisiae. Mol Cell Biol 23 (2003) 5972-5978
76. Laribee R.N., Krogan N.J., Xiao T., Shibata Y., Hughes T.R., Greenblatt J.F., et al. BUR kinase selectively regulates H3 K4 trimethylation and H2B ubiquitilation through recruitment of the PAF elongation complex. Curr Biol 15 (2005) 1487-1493
77. Lewis J.D., Meehan R.R., Henzel W.J., Maurer-Fogy I., Jeppesen P., Klein F., et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69 (1992) 905-914
78. Lossie A.C., Whitney M.M., Amidon D., Dong H.J., Chen P., Theriaque D., et al. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 38 (2001) 834-845
79. Lu P.J., Sundquist K., Baeckstrom D., Poulsom R., Hanby A., Meier-Ewert S., et al. A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem 274 (1999) 15633-15645
80. Lu Q., Kaplan M., Ray D., Ray D., Zacharek S., Gutsch D., et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 46 (2002) 1282-1291
81. Lu Q., Wu A., and Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 174 (2005) 6212-6219
82. Luger K., Mader A.W., Richmond R.K., Sargent D.F., and Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389 (1997) 251-260
83. Lujambio A., Ropero S., Ballestar E., Fraga M.F., Cerrato C., Setien F., et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67 (2007) 1424-1429
84. Mack G.S. Epigenetic cancer therapy makes headway. J Natl Cancer Inst 98 (2006) 1443-1444
85. Marks P.A., and Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 25 (2007) 84-90
86. Martens J.H., O'Sullivan R.J., Braunschweig U., Opravil S., Radolf M., Steinlein P., et al. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J 24 (2005) 800-812
87. McCall C.E., and Yoza B.K. Gene silencing in severe systemic inflammation. Am J Respir Crit Care Med 175 (2007) 763-767
88. Meehan R., Lewis J., Cross S., Nan X., Jeppesen P., and Bird A. Transcriptional repression by methylation of CpG. J Cell Sci Suppl 16 (1992) 9-14
89. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C., et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1 (1995) 686-692
90. Metzger E., Wissmann M., Yin N., Muller J.M., Schneider R., Peters A.H., et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437 (2005) 436-439
91. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007) 553-560
92. Miller T., Krogan N.J., Dover J., Erdjument-Bromage H., Tempst P., Johnston M., et al. COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Natl Acad Sci USA 98 (2001) 12902-12907
93. Monk M. Genomic imprinting. Genes Dev 2 (1988) 921-925
94. Morgan H.D., Santos F., Green K., Dean W., and Reik W. Epigenetic reprogramming in mammals. Hum Mol Genet 14 Spec No 1 (2005) R47-R58
95. Morison I.M., and Reeve A.E. A catalogue of imprinted genes and parent-of-origin effects in humans and animals. Hum Mol Genet 7 (1998) 1599-1609
96. Muller C.I., Ruter B., Koeffler H.P., and Lubbert M. DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML. Curr Pharm Biotechnol 7 (2006) 315-321
97. Nakamura N., and Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 16 (1998) 471-479
98. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (1998) 386-389
99. Nicholls R.D., and Knepper J.L. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2 (2001) 153-175
100. Oberle I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252 (1991) 1097-1102
101. Oki Y., Aoki E., and Issa J.P. Decitabine-bedside to bench. Crit Rev Oncol Hematol 61 (2007) 140-152
102. Oue N., Oshimo Y., Nakayama H., Ito R., Yoshida K., Matsusaki K., et al. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 94 (2003) 901-905
103. Pena P.V., Davrazou F., Shi X., Walter K.L., Verkhusha V.V., Gozani O., et al. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 442 (2006) 100-103
104. Peters A.H., Kubicek S., Mechtler K., O'Sullivan R.J., Derijck A.A., Perez-Burgos L., et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 12 (2003) 1577-1589
105. Piyathilake C.J., Henao O., Frost A.R., Macaluso M., Bell W.C., Johanning G.L., et al. Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes Control 14 (2003) 37-42
106. Qu G., Dubeau L., Narayan A., Yu M.C., and Ehrlich M. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat Res 423 (1999) 91-101
107. Qu G.Z., Grundy P.E., Narayan A., and Ehrlich M. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet 109 (1999) 34-39
108. Rahman A., and Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 358 (2008) 929-939
109. Reik W., Dean W., and Walter J. Epigenetic reprogramming in mammalian development. Science 293 (2001) 1089-1093
110. Richardson B. Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum Immunol 17 (1986) 456-470
111. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 3 (2007) 521-527
112. Richardson B.C., Strahler J.R., Pivirotto T.S., Quddus J., Bayliss G.E., Gross L.A., et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 35 (1992) 647-662
113. Ringrose L., and Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 38 (2004) 413-443
114. Robertson K.D. DNA methylation and human disease. Nat Rev Genet 6 (2005) 597-610
115. Roder K., Hung M.S., Lee T.L., Lin T.Y., Xiao H., Isobe K.I., et al. Transcriptional repression by Drosophila methyl-CpG-binding proteins. Mol Cell Biol 20 (2000) 7401-7409
116. Rountree M.R., Bachman K.E., and Baylin S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 25 (2000) 269-277
117. Runte M., Farber C., Lich C., Zeschnigk M., Buchholz T., Smith A., et al. Comprehensive methylation analysis in typical and atypical PWS and AS patients with normal biparental chromosomes 15. Eur J Hum Genet 9 (2001) 519-526
118. Russo V.E.A., Martienssen R.A., and Riggs A.D. Epigenetic mechanisms of gene regulation (1996), Cold Spring Harbor Laboratory Press, Woodbury
119. Ruthenburg A.J., Li H., Patel D.J., and Allis C.D. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8 (2007) 983-994
120. Ruthenburg A.J., Wang W., Graybosch D.M., Li H., Allis C.D., Patel D.J., et al. Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex. Nat Struct Mol Biol 13 (2006) 704-712
121. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9 (2006) 435-443
122. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
123. Santos F., Hendrich B., Reik W., and Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol 241 (2002) 172-182
124. Sato N., Maitra A., Fukushima N., van Heek N.T., Matsubayashi H., Iacobuzio-Donahue C.A., et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 63 (2003) 4158-4166
125. Schaefer C.B., Ooi S.K., Bestor T.H., and Bourc'his D. Epigenetic decisions in mammalian germ cells. Science 316 (2007) 398-399
126. Schneider R., Bannister A.J., and Kouzarides T. Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 27 (2002) 396-402
127. Schreiber J., Jenner R.G., Murray H.L., Gerber G.K., Gifford D.K., and Young R.A. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci USA 103 (2006) 5899-5904
128. Schuettengruber B., Chourrout D., Vervoort M., Leblanc B., and Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 128 (2007) 735-745
129. Schulz W.A., Steinhoff C., and Florl A.R. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 310 (2006) 211-250
130. Shemer R., Hershko A.Y., Perk J., Mostoslavsky R., Tsuberi B., Cedar H., et al. The imprinting box of the Prader-Willi/Angelman syndrome domain. Nat Genet 26 (2000) 440-443
131. Shi X., Hong T., Walter K.L., Ewalt M., Michishita E., Hung T., et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442 (2006) 96-99
132. Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet 8 (2007) 829-833
133. Sims III R.J., Belotserkovskaya R., and Reinberg D. Elongation by RNA polymerase II: the short and long of it. Genes Dev 18 (2004) 2437-2468
134. Sims III R.J., and Reinberg D. Histone H3 Lys 4 methylation: caught in a bind?. Genes Dev 20 (2006) 2779-2786
135. St Clair D., Xu M., Wang P., Yu Y., Fang Y., Zhang F., et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 294 (2005) 557-562
136. Strahl B.D., Grant P.A., Briggs S.D., Sun Z.W., Bone J.R., Caldwell J.A., et al. Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression. Mol Cell Biol 22 (2002) 1298-1306
137. Susser E., Hoek H.W., and Brown A. Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am J Epidemiol 147 (1998) 213-216
138. Susser E., Neugebauer R., Hoek H.W., Brown A.S., Lin S., Labovitz D., et al. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry 53 (1996) 25-31
139. Sutcliffe J.S., Nakao M., Christian S., Orstavik K.H., Tommerup N., Ledbetter D.H., et al. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet 8 (1994) 52-58
140. Sutherland G.R. Rare fragile sites. Cytogenet Genome Res 100 (2003) 77-84
141. Tamaru H., and Selker E.U. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414 (2001) 277-283
142. Tang W.Y., and Ho S.M. Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord 8 (2007) 173-182
143. Tenney K., and Shilatifard A. A COMPASS in the voyage of defining the role of trithorax/MLL-containing complexes: linking leukemogensis to covalent modifications of chromatin. J Cell Biochem 95 (2005) 429-436
144. Turner B.M. Histone acetylation and an epigenetic code. Bioessays 22 (2000) 836-845
145. Vakoc C.R., Mandat S.A., Olenchock B.A., and Blobel G.A. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell 19 (2005) 381-391
146. Vanden Berghe W., Ndlovu M.N., Hoya-Arias R., Dijsselbloem N., Gerlo S., and Haegeman G. Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. Biochem Pharmacol 72 (2006) 1114-1131
147. Waddington C.H. Preliminary notes on the development of the wings in normal and mutant strains of drosophila. Proc Natl Acad Sci USA 25 (1939) 299-307
148. Wade P.A., Gegonne A., Jones P.L., Ballestar E., Aubry F., and Wolffe A.P. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23 (1999) 62-66
149. Wang S.H., and Baker J.R. The role of apoptosis in thyroid autoimmunity. Thyroid 17 (2007) 975-979
150. Wang Z., Zang C., Rosenfeld J.A., Schones D.E., Barski A., Cuddapah S., et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40 (2008) 897-903
151. Waterland R.A., Dolinoy D.C., Lin J.R., Smith C.A., Shi X., and Tahiliani K.G. Maternal methyl supplements increase offspring DNA methylation at axin fused. Genesis 44 (2006) 401-406
152. Waterland R.A., and Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23 (2003) 5293-5300
153. Wilson I.M., Davies J.J., Weber M., Brown C.J., Alvarez C.E., MacAulay C., et al. Epigenomics: mapping the methylome. Cell Cycle 5 (2006) 155-158
154. Wood A.J., and Oakey R.J. Genomic imprinting in mammals: emerging themes and established theories. PLoS Genet 2 (2006) e147
155. Woodson K., Mason J., Choi S.W., Hartman T., Tangrea J., Virtamo J., et al. Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer. Cancer Epidemiol Biomarkers Prev 10 (2001) 69-74
156. Yang X.J., and Ullah M. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells. Oncogene 26 (2007) 5408-5419
157. Yang Z.Q., Imoto I., Fukuda Y., Pimkhaokham A., Shimada Y., Imamura M., et al. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 60 (2000) 4735-4739
158. Yasui D.H., Peddada S., Bieda M.C., Vallero R.O., Hogart A., Nagarajan R.P., et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 104 (2007) 19416-19421
159. Yoder J.A., Walsh C.P., and Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13 (1997) 335-340
160. Ziegler-Heitbrock H.W., Wedel A., Schraut W., Strobel M., Wendelgass P., Sternsdorf T., et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269 (1994) 17001-17004